Epidemiological Trend Analysis and Survival Data of Balinese with Soft-Tissue Sarcoma in 2015–2021

I. Wayan Sudarsa; Citra Aryanti

doi:10.3889/oamjms.2022.9770

Authors

I. Wayan Sudarsa Department of Surgery, Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
Citra Aryanti Department of Surgery, Division of Surgical Oncology, Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9770

Keywords:

Soft-tissue sarcoma, Incidence, Mortality, Survival, Subtype

Abstract

BACKGROUND: Soft tissue sarcoma (STS) has a very heterogen features of its nature, subtypes, and clincial behaviour among population. Regardless, the epidemiology data of soft tissue sarcoma is very limited in developing countries, including Indonesia.

AIM: To decribe the incidence and mortality trend analysis, as long as the survival data in Bali from 2015 to 2020.

METHODS: This is a case control study including all subjects with STS in Denpasar, Bali, Indonesia from January 2015 to September 2021. Data about demographics, clinical, and survival timing data were collected from Cancer Registry. Soft tissue sarcoma diagnosis was confirmed after histopathological examination. Joinpoint regression was used for crude rate trend analysis. Data was analyzed by SPSS 22.0, using Kaplan-Meier for survival analysis.

RESULTS: Ninety three subjects with STS were included in this study. Most patients died at the end of the study (65.6%) with median survival of only 30 months. The trend of STS age-standardized incidence and mortality rate was increasing from 2015 to 2018, then declining until 2020. The survival rate varies among the soft tissue sarcoma subtypes and location. It was better in the group without metastases, underwent therapy, but not statistically significant.

CONCLUSION: Soft tissue sarcoma showed a diversity of demographic and clinical parameters. The incidence and mortality rate has plateued in 2018, but then declining. The survival rate diversed regarding of the STS subtype, location, metastasis, and treatment given.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Naing KW, Monjazeb AM, Li CS, Lee LY, Yang A, Borys D, et al. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis. J Surg Oncol. 2015;111(2):158-64. https://doi.org/10.1002/jso.23780 PMid:25176165 DOI: https://doi.org/10.1002/jso.23780

Jacobs AJ, Morris CD, Levin AS. Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas. Clin Orthop Relat Res. 2018;476(3):589-598. https://doi.org/10.1007/s11999.0000000000000057 PMid:29529647 DOI: https://doi.org/10.1007/s11999.0000000000000057

Vodanovich DA, Choong PF. Soft-tissue sarcomas. Indian J Orthop. 2018;52(1):35-44. https://doi.org/10.4103/ortho.IJOrtho_220_17 PMid:29416168 DOI: https://doi.org/10.4103/ortho.IJOrtho_220_17

Edwards D, Voronina A, Attwood K, Grand’Maison A. Association between occupational exposures and sarcoma incidence and mortality: Systematic review and meta-analysis. Syst Rev. 2021;10(1):231-9. https://doi.org/10.1186/s13643-021-01769-4 DOI: https://doi.org/10.1186/s13643-021-01769-4

Gage MM, Nagarajan N, Ruck JM, Canner JK, Khan S, Giuliano K, et al. Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget. 2019;10(25):2462-74. https://doi.org/10.18632/oncotarget.26809 PMid:31069009 DOI: https://doi.org/10.18632/oncotarget.26809

Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project. Eur J Cancer. 2013;49(3):684-95. https://doi.org/10.1016/j.ejca.2012.09.011 PMid:23079473 DOI: https://doi.org/10.1016/j.ejca.2012.09.011

Ngan R, Wang E, Porter D, Desai J, Prayogo N, Devi B, et al. Soft-tissue sarcomas in the Asia-Pacific region: A systematic review. Asian Pac J Cancer Prev. 2013;14(11):6821-32. https://doi.org/10.7314/apjcp.2013.14.11.6821 PMid:24377612 DOI: https://doi.org/10.7314/APJCP.2013.14.11.6821

Arfiana W, Burhanudidn L, Fidiawati WA. The distribution of soft tissue sarcoma based on histopathology’s check-in Pekanbaru’s Hospital between 2009-2013. Jom FK. 2016;3(1):1-9.

Clark MA, Fischer C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701-11. https://doi.org/10.1056/NEJMra041866 PMid:16107623 DOI: https://doi.org/10.1056/NEJMra041866

Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015;152(4):223-30. https://doi.org/10.1016/j.jviscsurg.2015.05.001 PMid:26088366 DOI: https://doi.org/10.1016/j.jviscsurg.2015.05.001

Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182. https://doi.org/10.1155/2010/506182 PMid:20634933 DOI: https://doi.org/10.1155/2010/506182

Quek RH, Farid M, Wang E, Asavamongkolkul AM, Leung A, Prayogo N, et al. Epidemiology, treatment (tx) patterns and outcomes in Asian soft tissue sarcoma (STS) patients: Results from the Soft Tissue Sarcoma in the Asia Pacific Region (STAR) study. J Clin Oncol. 2015;33(15):10549. DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.10549